NEW YORK (GenomeWeb) – German molecular diagnostics firm Curetis and BGI Group subsidiary MGI said today they plan to codevelop next-generation sequencing-based in vitro diagnostic assays for microbial infections.

The two firms have signed a broad memorandum of understanding to develop IVD assays targeting an array of pathogens and genetic and antibiotic resistance markers. The firms plan to combine Curetis' PCR platform, the Unyvero L4 Lysator, with MGI's SP100 Sample Preparation System and MGISeq NGS sequencers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.